ASRT
Assertio Therapeutics IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$124.13M
P/E Ratio
—
EPS
$-0.32
Beta
0.43
52W High
$20.45
52W Low
$7.71
50-Day MA
$13.30
200-Day MA
$11.89
Dividend Yield
—
Profit Margin
-25.60%
Forward P/E
23.87
PEG Ratio
1.50
About Assertio Therapeutics Inc
Assertio Holdings, Inc., a commercial pharmaceutical company, provides medications in the areas of neurology, hospital, and pain and inflammation. The company is headquartered in Lake Forest, Illinois.
Fundamentals
| Revenue (TTM) | $118.71M |
| Gross Profit (TTM) | $83.33M |
| EBITDA | $12.78M |
| Operating Margin | -105.20% |
| Return on Equity | -28.20% |
| Return on Assets | -3.90% |
| Revenue/Share (TTM) | $18.54 |
| Book Value | $14.63 |
| Price-to-Book | 1.31 |
| Price-to-Sales (TTM) | 1.05 |
| EV/Revenue | 0.839 |
| EV/EBITDA | 37.39 |
| Quarterly Earnings Growth (YoY) | -18.80% |
| Quarterly Revenue Growth (YoY) | -57.90% |
| Shares Outstanding | $6.45M |
| Float | $5.73M |
| % Insiders | 2.06% |
| % Institutions | 33.20% |
Analyst Ratings
Consensus ($38.25 target)
1
Strong Buy3
BuyData last updated: 4/7/2026